Label: UQORA MAXIMUM UTI PAIN RELIEF AND FLUSH CONVENIENCE BUNDLE- phenazopyridine hydrochloride kit
- NDC Code(s): 73712-114-12, 73712-600-12
- Packager: Bonafide Health, LLC dba Uqora
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated November 10, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
Uqora Maximum UTI Pain Relief
Drug Facts
Purpose
Active ingredient (in each tablet)
Purpose Phenazopyridine Hydrochloride 99.5mg Urinary Tract Analgesic Use
Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.
Warnings
Do not exceed recommended dosage
Do Not Use
Do not use:
- If you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician
Ask A Doctor Before Use
Ask a doctor before use if you have:
- kidney disease
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to phenazopyridine
When Using This Product
When using this product:
- stomach upset may occur, taking this product with or after meals may reduce stomach upset
- your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
Stop Use And Ask A Doctor
Stop use and ask a doctor if:
- your symptoms last for more than 2 days
- you suspect you are having an adverse reaction to the medication
Long Term Administration
Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver). Although
no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.Directions
Adults and children 12 years and over:
take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
Do not use for more than 2 days (12 tablets) without consulting a doctor.Children under 12 years:consult a doctor
Other Information
- this product may stain contact lenses
- this product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
- store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light
- Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged
- Additional Items
-
Principal Display Panel
uqora
Founded by a UTI Sufferer
Get Relief
Get Ahead
Convenience Bundle Pack
UTI Pain Relief Max Strength*
Fast targeted relief for pain, burning & urgency
2 Day Supply
12 tablets
99.5 mg Phenazopyridine Hydrochloride
Packaged for convenience.
Not intended to replace medical care.
*Most powerful dose without an Rx.
&
Flush Urinary Tract Drink Mix
Clinical Strength
D-Mannose per serving
Flushes your urinary tract + immune support*
Pink Lemonade Flavor
2 packets
Dietary Supplement
Net Wt. 0.3OZ(10G
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
-
INGREDIENTS AND APPEARANCE
UQORA MAXIMUM UTI PAIN RELIEF AND FLUSH CONVENIENCE BUNDLE
phenazopyridine hydrochloride kitProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:73712-600 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:73712-600-12 1 in 1 KIT; Type 0: Not a Combination Product 11/10/2025 Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BLISTER PACK 12 Part 2 1 PACKET 2 Part 1 of 2 UQORA MAXIMUM UTI PAIN RELIEF
phenazopyridine hydrochloride tabletProduct Information Item Code (Source) NDC:73712-114 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE 99.5 mg Inactive Ingredients Ingredient Name Strength POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G) POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) TALC (UNII: 7SEV7J4R1U) TRIACETIN (UNII: XHX3C3X673) STARCH, CORN (UNII: O8232NY3SJ) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color brown Score no score Shape OVAL Size 9mm Flavor Imprint Code p99 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:73712-114-12 1 in 1 CARTON 1 12 in 1 BLISTER PACK; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 11/10/2025 Part 2 of 2 FLUSH
d-mannose, potassium, magnesium calcium, vitamin b6, vitamin c powderProduct Information Route of Administration ORAL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 2 in 1 PACKET; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date DIETARY SUPPLEMENT 11/10/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 11/10/2025 Labeler - Bonafide Health, LLC dba Uqora (118327455) Establishment Name Address ID/FEI Business Operations Pharbest 557054835 manufacture(73712-600, 73712-114)